Marizyme

Marizyme Current Liabilities

The Current Liabilities of Marizyme (MRZM) as of Nov 5, 2026 is 22.64 M USD. In the previous year, Current Liabilities was 38.10 M USD — a change of -40.58% (lower).

Current Liabilities

22.64 MUSD

YoY

-40.58%

Last updated:

Current Liabilities of Marizyme is 2024 22.64 M USD. Current Liabilities of Marizyme was 2023 38.10 M USD. It decreases by -40.58% lower compared to the previous year.

The Marizyme Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2017
652,670.00 USD
Jan 1, 2018
42,780.00 USD
Jan 1, 2019
270,218.00 USD
Jan 1, 2020
964,695.00 USD
Jan 1, 2021
3.54 M USD
Jan 1, 2022
4.62 M USD
Jan 1, 2023
38.10 M USD
Jan 1, 2024
22.64 M USD
The Marizyme Current Liabilities history
YEARCurrent LiabilitiesYoY
22.64 MUSD-40.58%
38.10 MUSD+724.96%
4.62 MUSD+30.53%
3.54 MUSD+266.81%
964,695.00USD+257.01%
270,218.00USD+531.65%
42,780.00USD-93.45%
652,670.00USD+115.89%
302,321.00USD-92.95%
4.29 MUSD+95.38%
2.19 MUSD+69.44%
1.29 MUSD-89.66%
12.52 MUSD-34.65%
19.16 MUSD+17.19%
16.35 MUSD+40,775.00%
40,000.00USD+100.00%
20,000.00USD-50.00%
40,000.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Marizyme Stock analysis

What does Marizyme do? Marizyme Inc. is a biotechnology company focused on the development of enzymes and enzyme products. The company was founded in 2011 and is based in Sarasota, Florida. Marizyme has gained recognition in recent years through innovative technologies, research, and collaboration with leading partners worldwide. Marizyme's business model is centered around the development and commercialization of enzyme products for medical, dermatological, agricultural, and industrial applications. The company has developed a wide range of enzymatic products to address various uses, including enzymes for wound healing, removal of biofilm-based infections, inflammation and impurities, food preservation, cleaning of chemically contaminated groundwater, among others. The company has several divisions, including: 1. Medical Division: Marizyme has developed a wide range of enzymatic products for wound healing, including an innovative hydroactive gel that can remove biofilm-based infections faster and more effectively than conventional methods. 2. Dermatological Division: The company offers enzymatic products for the removal of skin imperfections such as acne, hyperpigmentation, age spots, and melasma. 3. Agricultural Division: Marizyme has also developed enzymatic products for agriculture, including products to enhance the shelf life of fruits and vegetables, improve the quality of dairy products, and combat plant diseases. 4. Industrial Division: The company also offers enzymatic products for industrial cleaning, removal of heavy metals, odor neutralization, and water and soil remediation. Marizyme has an experienced team and close relationships with leading partners worldwide to ensure research and development at the highest level. The company prioritizes quality and safety in its products to achieve the best results for its customers. Overall, Marizyme has taken a strong leadership role in the enzyme industry. The company has developed innovative technologies to utilize enzyme products in a variety of applications for different industries. Marizyme sets high standards for quality and safety of its products and has a bright future ahead. Marizyme is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Marizyme stock

Current Liabilities of Marizyme is 22.64 M USD in 2024.

Current Liabilities of Marizyme changed from 38.10 M USD to 22.64 M USD, representing a -40.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Marizyme since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Marizyme historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Marizyme

All Key Metrics — Marizyme